MEOX2 and central nervous system cancer: Our results demonstrated that MEOX2 was upregulated in glioma, particularly in GBM, and it is significantly positively correlated with the prognosis of glioma patients; suggesting that MEOX2 has the potential to be prognostic markers for glioma.